BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26269564)

  • 1. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.
    Nash SH; Till C; Song X; Lucia MS; Parnes HL; Thompson IM; Lippman SM; Platz EA; Schenk J
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1507-15. PubMed ID: 26269564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum β-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study.
    Karppi J; Kurl S; Laukkanen JA; Kauhanen J
    Nutr Cancer; 2012 Apr; 64(3):361-7. PubMed ID: 22420939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
    Kristal AR; Till C; Platz EA; Song X; King IB; Neuhouser ML; Ambrosone CB; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):638-46. PubMed ID: 21335507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
    Key TJ; Appleby PN; Travis RC; Albanes D; Alberg AJ; Barricarte A; Black A; Boeing H; Bueno-de-Mesquita HB; Chan JM; Chen C; Cook MB; Donovan JL; Galan P; Gilbert R; Giles GG; Giovannucci E; Goodman GE; Goodman PJ; Gunter MJ; Hamdy FC; Heliövaara M; Helzlsouer KJ; Henderson BE; Hercberg S; Hoffman-Bolton J; Hoover RN; Johansson M; Khaw KT; King IB; Knekt P; Kolonel LN; Le Marchand L; Männistö S; Martin RM; Meyer HE; Mondul AM; Moy KA; Neal DE; Neuhouser ML; Palli D; Platz EA; Pouchieu C; Rissanen H; Schenk JM; Severi G; Stampfer MJ; Tjønneland A; Touvier M; Trichopoulou A; Weinstein SJ; Ziegler RG; Zhou CK; Allen NE;
    Am J Clin Nutr; 2015 Nov; 102(5):1142-57. PubMed ID: 26447150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands).
    Schuurman AG; Goldbohm RA; Brants HA; van den Brandt PA
    Cancer Causes Control; 2002 Aug; 13(6):573-82. PubMed ID: 12195647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk.
    Beilby J; Ambrosini GL; Rossi E; de Klerk NH; Musk AW
    Eur J Clin Nutr; 2010 Oct; 64(10):1235-8. PubMed ID: 20683458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.
    Key TJ; Appleby PN; Allen NE; Travis RC; Roddam AW; Jenab M; Egevad L; Tjønneland A; Johnsen NF; Overvad K; Linseisen J; Rohrmann S; Boeing H; Pischon T; Psaltopoulou T; Trichopoulou A; Trichopoulos D; Palli D; Vineis P; Tumino R; Berrino F; Kiemeney L; Bueno-de-Mesquita HB; Quirós JR; González CA; Martinez C; Larrañaga N; Chirlaque MD; Ardanaz E; Stattin P; Hallmans G; Khaw KT; Bingham S; Slimani N; Ferrari P; Rinaldi S; Riboli E
    Am J Clin Nutr; 2007 Sep; 86(3):672-81. PubMed ID: 17823432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer.
    Hsing AW; Comstock GW; Abbey H; Polk BF
    J Natl Cancer Inst; 1990 Jun; 82(11):941-6. PubMed ID: 2342127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.
    Nordström T; Van Blarigan EL; Ngo V; Roy R; Weinberg V; Song X; Simko J; Carroll PR; Chan JM; Paris PL
    Prostate; 2016 Mar; 76(4):339-48. PubMed ID: 26585352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study.
    Pouchieu C; Galan P; Ducros V; Latino-Martel P; Hercberg S; Touvier M
    Nutr Cancer; 2014; 66(6):980-8. PubMed ID: 25072980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum carotenoid and retinol levels in African-Caribbean Tobagonian men with high prostate cancer risk in comparison with African-American men.
    McDonald AC; Bunker CH; Raman J; Richie J; Patrick AL
    Br J Nutr; 2017 Apr; 117(8):1128-1136. PubMed ID: 28490387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum vitamin A and carotenoid levels with markers of prostate cancer detection among US men.
    Beydoun HA; Shroff MR; Mohan R; Beydoun MA
    Cancer Causes Control; 2011 Nov; 22(11):1483-95. PubMed ID: 21800039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Schenk JM; Riboli E; Chatterjee N; Leitzmann MF; Ahn J; Albanes D; Reding DJ; Wang Y; Friesen MD; Hayes RB; Peters U
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1227-31. PubMed ID: 19336558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinol, carotenoids and the risk of prostate cancer: a case-control study from Italy.
    Bosetti C; Talamini R; Montella M; Negri E; Conti E; Franceschi S; La Vecchia C
    Int J Cancer; 2004 Nov; 112(4):689-92. PubMed ID: 15382052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.
    Watters JL; Gail MH; Weinstein SJ; Virtamo J; Albanes D
    Cancer Res; 2009 May; 69(9):3833-41. PubMed ID: 19383902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.